CRIS
Curis IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.54M
P/E Ratio
—
EPS
$-0.58
Beta
3.06
52W High
$3.13
52W Low
$0.46
50-Day MA
$0.60
200-Day MA
$1.14
Dividend Yield
—
Profit Margin
-299.70%
Forward P/E
—
PEG Ratio
0.00
About Curis Inc
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
Fundamentals
| Revenue (TTM) | $7.06M |
| Gross Profit (TTM) | $-21.22M |
| EBITDA | $-34.11M |
| Operating Margin | -485.10% |
| Return on Equity | -694.00% |
| Return on Assets | -62.10% |
| Revenue/Share (TTM) | $0.45 |
| Book Value | $0.42 |
| Price-to-Book | 1.50 |
| Price-to-Sales (TTM) | 2.77 |
| EV/Revenue | 0.77 |
| EV/EBITDA | 0.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -66.00% |
| Shares Outstanding | $38.98M |
| Float | $16.03M |
| % Insiders | 7.95% |
| % Institutions | 40.50% |
Historical Volatility
HV 10-Day
62.22%
HV 20-Day
65.33%
HV 30-Day
99.02%
HV 60-Day
94.19%
HV Rank
77.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.00 target)
1
Strong Buy3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026